Pandemics and technology engagement: New evidence from m‐Health intervention during COVID‐19 in India

Abstract

Information provision for social welfare via cheap technological media is now a widely available tool used by policymakers. Often, however, an ample supply of information does not translate into high consumption of information due to various frictions in demand, possibly stemming from the pecuniary and non‐pecuniary cost of engagement, along with institutional factors. We test this hypothesis in the Indian context using a unique data set comprising 2 million call records of enrolled users of ARMMAN, a Mumbai‐based nongovernmental organization that sends timely informational calls to mobile phones of less‐privileged pregnant women. The strict lockdown induced by COVID‐19 in India was an unexpected shock on engagement with m‐Health technology, in terms of both reductions in market wages and increased time availability at home. Using a difference‐in‐differences design on unique calls tracked at the user‐time level with fine‐grained time‐stamps on calls, we find that during the lockdown period, the call durations increased by 1.53 percentage points. However, technology engagement behavior exhibited demographic heterogeneity increasing relatively after the lockdown for women who had to borrow the phones vis‐à‐vis phone owners, for those enrolled in direct outreach programs vis‐à‐vis self‐registered women, and for those who belonged to the low‐income group vis‐à‐vis high‐income group. These findings are robust with coarsened exact matching and with a placebo test for a 2017–2018 sample. Our results have policy implications around demand‐side frictions for technology engagement in developing economies and maternal health.

The advancement of artificial intelligence in biomedical research and health innovation: challenges and opportunities in emerging economies

“…Reliable health systems are key to supporting clinical innovation and access to health technologies. During the Covid-19 pandemic, for example, in countries like China, Brazil, and India, collaborations between scientists, technology developers, and public health systems facilitated development and distribution of locally produced Covid-19 test kits, thanks to ad-hoc coordination between universities, regional science policy instruments, state laboratories, regulators, and health systems [86][87][88]. Thus, health systems could play a critical role in collecting patient data to support research, and in creating new platforms in the early stages of AE development [89].…”

The Impact of Mobile Health Interventions on Service Users' health outcomes and the role of health professions: A systematic review of systematic reviews- Protocol.

“…In India, patients' engagement and utilisation of mHealth increased dramatically during lockdown (15). In Brazil, a randomised controlled trial (RCT) found that using mHealth tools was an effective means of communicating with the public to enhance people's adherence to preventive measures for COVID-19 (16).…”